stroke
Conditions
Interventions
Western medicine and Xiaoshuan Changrong capsule group:Western medicine and Xiaoshuan Changrong capsule
Western medicine group :Western medicine
Healthy control group:None
Sponsors
Shanxi University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
35 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients who meet the diagnosis of acute cerebral infarction and are confirmed by CT or MRI; 2. NIHSS score: 4-15 (including 4 and 15 points); 3. Patients aged between 35 and 75 years; 4. Onset time within 7 days; 5. Patients with stable vital signs, clear consciousness and no serious complications; 6. Patients with first onset or previous history of stroke without limb paralysis and other sequelae; 7. Good compliance with this study; 8. Patients or family members sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with stroke caused by cerebrovascular inflammatory reaction; 2. Patients with stroke caused by cardiogenic factors such as atrial fibrillation; 3. Patients with acute cerebral infarction or repeated cerebral infarction; 4. Hemorrhagic disease; 5. Pregnant and lactating patients; 6. Patients with hearing and other dysfunction who cannot cooperate with the assessment; 7. Participated in other clinical trials within the last 90 days.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum levels of Nogo-A and NgR1;RhoA and ROCK levels in serum; | — |
Countries
China
Contacts
Public ContactHu Fengyun
Outcome results
None listed